Cargando…

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma

Background: Proton beam has an excellent depth dose distribution due to its unique physical properties, and thus proton beam therapy (PBT) has been tried and showed promising outcomes in hepatocellular carcinoma (HCC). The purpose of this phase II study is to evaluate the efficacy of hypofractionate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Tae Hyun, Park, Joong-Won, Kim, Bo Hyun, Oh, Eun Sang, Youn, Sang Hee, Moon, Sung Ho, Kim, Sang Soo, Woo, Sang Myung, Koh, Young-Hwan, Lee, Woo Jin, Kim, Dae Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198869/ https://www.ncbi.nlm.nih.gov/pubmed/32411594 http://dx.doi.org/10.3389/fonc.2020.00542

Ejemplares similares

Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2017)

Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2022)

Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2015)

Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma?
por: Kim, Tae Hyun, et al.
Publicado: (2019)

Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade
por: Kim, Tae Hyun, et al.
Publicado: (2022)

Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer
por: Kim, Tae Hyun, et al.
Publicado: (2021)

Efficacy and feasibility of proton beam radiotherapy using the simultaneous integrated boost technique for locally advanced pancreatic cancer
por: Kim, Tae Hyun, et al.
Publicado: (2020)

Effectiveness and Safety of Simultaneous Integrated Boost-Proton Beam Therapy for Localized Pancreatic Cancer
por: Kim, Tae Hyun, et al.
Publicado: (2018)

Beam Angle Optimization for Double-Scattering Proton Delivery Technique Using an Eclipse Application Programming Interface and Convolutional Neural Network
por: Cheon, Wonjoong, et al.
Publicado: (2021)

Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2019)

Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
por: Kim, Yeon-Joo, et al.
Publicado: (2013)

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma
por: Kim, Young-Il, et al.
Publicado: (2013)

Effectiveness and feasibility of concurrent chemoradiotherapy using simultaneous integrated boost-intensity modulated radiotherapy with and without induction chemotherapy for locally advanced pancreatic cancer
por: Oh, Eun Sang, et al.
Publicado: (2018)

Multi-Institutional Retrospective Study of Radiotherapy for Hepatocellular Carcinoma in the Caudate Lobe
por: Lee, Sung Uk, et al.
Publicado: (2021)

Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?
por: Yoo, Gyu Sang, et al.
Publicado: (2020)

Photon Versus Proton Beam Therapy for T1–3 Squamous Cell Carcinoma of the Thoracic Esophagus Without Lymph Node Metastasis
por: Suh, Yang-Gun, et al.
Publicado: (2021)

Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2018)

Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
por: Kim, Su-Hyun, et al.
Publicado: (2022)

Corrigendum: Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
por: Kim, Su-Hyun, et al.
Publicado: (2023)

Risk of Pancreatic Cancer in Relation to ABO Blood Group and Hepatitis C Virus Infection in Korea: A Case-Control Study
por: Woo, Sang Myung, et al.
Publicado: (2013)

A dummy-run evaluation of postoperative hypofractionated intensity-modulated radiation therapy (POHIM-RT) trials for cervical cancer
por: Cho, Won Kyung, et al.
Publicado: (2020)

Hypofractionated Radiotherapy With Volumetric Modulated Arc Therapy Decreases Postoperative Complications in Prosthetic Breast Reconstructions: A Clinicopathologic Study
por: Song, Seung Yong, et al.
Publicado: (2020)

Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
por: Park, Jongmoo, et al.
Publicado: (2018)

Hydrogen production by electrochemical reaction using ethylene glycol with terephthalic acid
por: Kim, Se-Hyun, et al.
Publicado: (2021)

Correction: Hydrogen production by electrochemical reaction using ethylene glycol with terephthalic acid
por: Kim, Se-Hyun, et al.
Publicado: (2021)

All-treatment array of hepatocellular carcinoma from initial diagnosis to death: observation of cumulative treatments
por: Moon, Hae, et al.
Publicado: (2017)

Brain Metastases From Lung Adenocarcinoma May Preferentially Involve the Distal Middle Cerebral Artery Territory and Cerebellum
por: Kwon, Hyeokjin, et al.
Publicado: (2020)

Corrigendum: Brain Metastases From Lung Adenocarcinoma May Preferentially Involve the Distal Middle Cerebral Artery Territory and Cerebellum
por: Kwon, Hyeokjin, et al.
Publicado: (2020)

Better survival of patients with hepatitis B virus-related hepatocellular carcinoma in South Korea: Changes in 16-years cohorts
por: Choi, Sang Il, et al.
Publicado: (2022)

Gene Expression Profiling Identifies Akt as a Target for Radiosensitization in Gastric Cancer Cells
por: Kim, Kyung Hwan, et al.
Publicado: (2020)

Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017
por: Bae, Bong Kyung, et al.
Publicado: (2022)

Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples
por: Choi, Sun Il, et al.
Publicado: (2019)

A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute
por: Choi, Jin-Ho, et al.
Publicado: (2022)

Hepatic arterial infusion chemotherapy versus systemic therapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis
por: Kim, Hyeon-Jong, et al.
Publicado: (2023)

Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma
por: Lee, Sung Uk, et al.
Publicado: (2023)

Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents
por: Yoo, Hae Won, et al.
Publicado: (2022)

Periodontal disease and cancer risk: A nationwide population-based cohort study
por: Kim, Eun Hwa, et al.
Publicado: (2022)

FLASH Radiotherapy Using Single-Energy Proton PBS Transmission Beams for Hypofractionation Liver Cancer: Dose and Dose Rate Quantification
por: Wei, Shouyi, et al.
Publicado: (2022)

Impact of supradiaphragmatic lymphadenectomy on the survival of patients in stage IVB ovarian cancer with thoracic lymph node metastasis
por: Park, Soo Jin, et al.
Publicado: (2023)

Comparison of VMAT‐SABR treatment plans with flattening filter (FF) and flattening filter‐free (FFF) beam for localized prostate cancer
por: Chung, Jin‐Beom, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0hitjgjn1ta8ts9g9f053p8adm